HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunological studies on sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses.

Abstract
The neuronal ceroid-lipofuscinoses constitute an important group of progressive encephalopathies leading to severe psychomotor retardation, blindness, and early death. They are characterized by accumulation of autofluorescent, electron-dense storage bodies within the cytoplasm of neurons and many other cell types. We have recently identified sphingolipid activator proteins A and D as major components of the storage cytosomes in the infantile form of NCL. Using an immunological approach we have shown that sphingolipid activator proteins also constitute an integral component of the storage bodies in the other major forms of the disease.
AuthorsM Haltia, J Tyynelä, M Baumann, M Henseler, K Sandhoff
JournalGerontology (Gerontology) Vol. 41 Suppl 2 Pg. 239-48 ( 1995) ISSN: 0304-324X [Print] Switzerland
PMID8821335 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glycoproteins
  • PSAP protein, human
  • Saposins
  • Sphingolipid Activator Proteins
  • Sphingolipids
Topics
  • Blotting, Western
  • Brain (ultrastructure)
  • Culture Techniques
  • Glycoproteins (analysis, metabolism)
  • Humans
  • Immunohistochemistry
  • Microscopy, Electron
  • Neuronal Ceroid-Lipofuscinoses (immunology, pathology)
  • Saposins
  • Sphingolipid Activator Proteins
  • Sphingolipids (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: